Perez-Vizcaino F - Search Results

1

Vitamin D and Pulmonary Arterial Hypertension.

Perez-Vizcaino F, Barberá JA, Rodríguez Chiaradía DA. Perez-Vizcaino F, et al. Arch Bronconeumol. 2024 Mar;60(3):131-132. doi: 10.1016/j.arbres.2023.11.006. Epub 2023 Nov 9. Arch Bronconeumol. 2024. PMID: 38008680 English, Spanish. No abstract available.

2

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.

Chamorro V, Morales-Cano D, Milara J, Barreira B, Moreno L, Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Cortijo J, Cogolludo Á, Barberá JA, Perez-Vizcaino F. Chamorro V, et al. PLoS One. 2018 Jan 24;13(1):e0191239. doi: 10.1371/journal.pone.0191239. eCollection 2018. PLoS One. 2018. PMID: 29364918 Free PMC article.

3

Impact of Nutrition on Pulmonary Arterial Hypertension.

Callejo M, Barberá JA, Duarte J, Perez-Vizcaino F. Callejo M, et al. Nutrients. 2020 Jan 7;12(1):169. doi: 10.3390/nu12010169. Nutrients. 2020. PMID: 31936113 Free PMC article. Review.

4

Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension.

Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Olivencia MA, Moreno L, Blanco I, Escribano-Subias P, Cogolludo A, Barbera JA, Perez-Vizcaino F. Callejo M, et al. J Clin Med. 2020 Feb 6;9(2):448. doi: 10.3390/jcm9020448. J Clin Med. 2020. PMID: 32041235 Free PMC article.

5

Oxygen-sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension.

Morales-Cano D, Barreira B, Navarro BO, Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Lorente JA, Moreno L, Barberá JA, Cogolludo Á, Perez-Vizcaino F. Morales-Cano D, et al. Antioxidants (Basel). 2021 Jan 21;10(2):155. doi: 10.3390/antiox10020155. Antioxidants (Basel). 2021. PMID: 33494520 Free PMC article.

6

Vitamin D deficiency, a potential cause for insufficient response to sildenafil in pulmonary arterial hypertension.

Callejo M, Blanco I, Barberá JA, Perez-Vizcaino F. Callejo M, et al. Eur Respir J. 2021 Nov 4;58(5):2101204. doi: 10.1183/13993003.01204-2021. Print 2021 Oct. Eur Respir J. 2021. PMID: 34385273 Free article. No abstract available.

7

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension.

Blanco I, Marquina M, Tura-Ceide O, Ferrer E, Ramírez AM, Lopez-Meseguer M, Callejo M, Perez-Vizcaino F, Peinado VI, Barberà JA. Blanco I, et al. Front Pharmacol. 2023 Apr 24;14:1145994. doi: 10.3389/fphar.2023.1145994. eCollection 2023. Front Pharmacol. 2023. PMID: 37188265 Free PMC article.

8

miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.

Mondejar-Parreño G, Callejo M, Barreira B, Morales-Cano D, Esquivel-Ruiz S, Moreno L, Cogolludo A, Perez-Vizcaino F. Mondejar-Parreño G, et al. J Physiol. 2019 Feb;597(4):1185-1197. doi: 10.1113/JP276054. Epub 2018 Jun 21. J Physiol. 2019. PMID: 29717493 Free PMC article.

9

Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome.

Callejo M, Mondejar-Parreño G, Barreira B, Izquierdo-Garcia JL, Morales-Cano D, Esquivel-Ruiz S, Moreno L, Cogolludo Á, Duarte J, Perez-Vizcaino F. Callejo M, et al. Sci Rep. 2018 Jun 26;8(1):9681. doi: 10.1038/s41598-018-27682-w. Sci Rep. 2018. PMID: 29946072 Free PMC article.

10

Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.

Morales-Cano D, Callejo M, Barreira B, Mondejar-Parreño G, Esquivel-Ruiz S, Ramos S, Martín MÁ, Cogolludo A, Moreno L, Perez-Vizcaino F. Morales-Cano D, et al. PLoS One. 2019 Jan 28;14(1):e0211281. doi: 10.1371/journal.pone.0211281. eCollection 2019. PLoS One. 2019. PMID: 30689673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page